Saturday, December 24, 2011

PHYTOCHEMICAL AND PRELIMINARY TOXICITY STUDY OF SESBANIA GRANDIFLORA (LINN.) FLOWERS

Sesbania grandiflora Linn. (Family : Fabaceae) is widespread distributed West Bengal, Assam, Karnataka and North-Eastern. The present study intended with various phytochemical screening and toxicity studies were carried out on the flowers of Sesbania grandiflora. Preliminary phytochemical evalution of the methanolic and aqueous extracts of revealed that presence of corbohydrate, proteins, amino acids, saponins, flavonoids, alkaloids, tannins and glycosides.The acute toxicity study were performed to determined LD50 ­ of 99% methanolic extract 20-40 mg/kg, 70% methanolic extract100-200 mg/kg and aqueous extract250-500 mg/kg.

Pandey Govind, Hepatogenic effect of some indigenous drugs on experimental liver damage. Phd thesis. Jabalpur, MP, India: JNKVV;1990

Kirthikar KR, Basu BD. Indian Medicinal plants Vol III. Dehradun: Bishen Singh Mahendra Pal Singh 1998: 735-36.

Das KC, Tripati AK.A new flavanol glycoside from Sesbania grandiflora (Linn.). Fitoterapia 1998; 69(5): 477-8

Asima Chatterjee, Satyesh Chandra Pakrashi. The Treatise on Indian Medicinal Plants Vol II. New Delhi: Publication and Information Directorate; 1992: 118

Mukherjee Pulok. k , “ Quality control of herbal drugs ”Business Horizons , 3-4, 2008

Jayaraman J. “Laboratory Manual in Biotechemistry. Published by birla publication New Delhi (I): 50-53, 1995.

Kar Ashutosh. “Pharmacognosy and Pharmabiotechnology.” Published by new age international, New Delhi (II): 147, 2007.

Singh S.P. “Practical Manual of Biochemistry.” (V) Published by CBS publishers & distributors New Delhi: 17-31, 2004.

Kokate CK, Ed. Practical Pharmacognosy. 4th ed. New Delhi: Vallabha Prakashan; 1999: 149-56.

Khandelwal KR. Practical Pharmacognosy techniques and experiments. 2nd ed. Pune: Nirali Prakashan; 2000: 149-56.

Mrs. Prema Veeraraghavan. Expert consultant, CPCSEA, OECD guideline No. 420.
Posted by at


Bioelectronic DNA detection involves forming an electronic circuit mediated by nucleic acid hybridization and it serves as the basis for a DNA detection system called eSensor™ [1-4]. This system uses low-density DNA chips containing electrodes coated with DNA capture probes. Target DNA present in the sample hybridizes specifically both to capture probes and ferrocene labeled signal probes in solution thereby generating an electric current. Currente Sensor DNA chips contain as many as 36 electrodes for simultaneous detection of multiple pathogens from a single sample.

Many pathogens cause both acute and chronic disease at relatively low copy number and may be difficult or impossible to propagate in culture. Thus, most pathogen detection systems rely on nucleic acid amplification by using polymerase chain reaction (PCR). One highly effective amplification strategy targets conserved sequences among the family of organisms of interest. Such broad-range PCR strategies have been used to identify and characterize several known and previously uncharacterized bacteria [5,6] and viruses [7,8]. In order to maximize the utility of these effective pathogen nucleic acid amplification systems, amplification needs to be coupled with rapid, sensitive, and specific detection. Bioelectronic DNA detection by use of the eSensor chip might fulfill this need.

Human papillomaviruses (HPV) serve as an ideal model system for determining the efficiency and feasibility of eSensor DNA detection technology since there are at least 30 distinct genital HPV types that can be effectively amplified with broad-range consensus PCR primers. We designed two eSensor chips, each containing 14 probes specific for the conserved L1 region of the HPV genome. We evaluated clinical cervical cytology samples known to contain one or more HPV types. The eSensor DNA detection platform successfully detected the correct HPV type in most of these clinical samples, demonstrating that the system provides a rapid, sensitive, specific, and economical approach for multiple-pathogen detection and identification from a single sample.Background We used human papillomaviruses (HPV) as a model system to evaluate the utility of a nucleic acid, hybridization-based bioelectronic DNA detection platform (eSensor) in identifying multiple pathogens.